Prof. Anne Dickinson is a Professor with the Translational and Clinical Research Institute within the Faculty of Medical Sciences, Newcastle upon Tyne, UK. Prof. Dickinson founded Alcyomics Ltd based on over 30 years experience with a human in vitro skin explant model for predicting graft-versus-host disease (GvHD), a severe allo-immune complication of haematopoietic stem cell transplantation. This skin model (Skimune®) is used within Alcyomics to predict allergy and sensitization to chemicals and drugs, including biologics and cellular therapies. Skimune® is patented in Europe and the US.
Dr. Terri Lehman has served as REPROCELL BioServe’s Chief Technical Officer since 1993. Terri is responsible for development and maintenance of all standard operating procedures (SOPs) for all research work, as well as quality control across all products and services.
Prior to BioServe, Terri was a post-doctoral fellow at the National Cancer Institute and National Institutes of Health. At these institutions she helped develop PCR and sequencing techniques to investigate point mutations in the p53 tumor suppressor gene and the ras protooncogene in a variety of human samples. Lehman received her Ph.D. from The Ohio State University in the Department of Physiological Chemistry.
REPROCELL Resources Online
© 2021 REPROCELL Inc. All rights reserved.